Last reviewed · How we verify
NCT06883058: CASA pre-pilot
Implementation of the Caregivers-Patients Support Coping with Advanced-Cancer (CASA) Intervention.
NA trial testing Caregivers-patients support intervention for advanced cancer (CASA) in Advanced Cancer in 30 participants. Not yet recruiting.
28 February 2026
Quick facts
| Lead sponsor | Ponce Medical School Foundation, Inc. |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 30 |
| Start date | 12 March 2025 |
| Primary completion | 28 February 2026 |
| Estimated completion | 28 February 2026 |
Drugs / interventions tested
- Caregivers-patients support intervention for advanced cancer (CASA)
- Placebo
Conditions studied
- Advanced Cancer — all drugs for Advanced Cancer →
- Caregivers — all drugs for Caregivers →
- Patients — all drugs for Patients →
- Stage III Cancer — all drugs for Stage III Cancer →
Sponsor
Ponce Medical School Foundation, Inc.
Who can join
Adults 21 to 105, any sex, with Advanced Cancer or Caregivers. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This pre-pilot aims to prepare the PI to receive hands-on experience in implementation and dissemination and design and lead pilot studies in palliative care. The catchment area communities experience lower cancer health outcomes and are more likely to be diagnosed with advanced cancer when compared to other surrounding areas. The PI's catchment area experiences advanced cancer, and their caregivers are at an increased risk for unmet psychosocial needs; this pre-pilot will allow the PI to focus on this critical gap in equal healthcare. The research goal of this proposal is to refine and pre-pilot an intervention titled Caregivers Patients Support to Cope with Advanced Cancer (CASA), a five-session, 60-minute telehealth series for patient-caregiver dyads. The rationale for this project is that it will lay the groundwork for a Randomized Control Trial (RCT) testing the efficacy of CASA. It will also assess the implementation of an innovative method to deliver the CASA intervention. This study aims to use the collaborative intervention planning framework and ORBIT model to modify and assess the feasibility and preliminary effect of the CASA intervention. The overall impact of this study is to improve access to psychosocial, culturally adapted interventions in the proposed catchment area.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06883058
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Advanced Cancer
Currently open trials in the same condition.
- NCT07393529 — A Pilot Randomized Controlled Trial of a Social Network Intervention · NA · recruiting
- NCT07382544 — Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss · Phase 1 · recruiting
- NCT07246954 — A Chaplain-clinician Led Spiritual Care (PEACE) Intervention on Spiritual/Religious Beliefs Related to Medical Care in P · NA · recruiting
- NCT06346197 — Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas · Phase 3 · recruiting
- NCT07147023 — Better Real-time Information on Documentation of Goals of Care for Engagement in Serious Illness Communication · NA · active not recruiting
Other Ponce Medical School Foundation, Inc. trials
Trials by the same sponsor.
- NCT07219264 — Mental Health CPR for Cancer Survivors · NA · recruiting
- NCT06844097 — Intervention for Medical Student to Promote Cervical Cancer Screening Among Latinx Transmasculine Individuals · NA · not yet recruiting
- NCT04910542 — Epidemiologic Intelligence Network (EpI-Net) to Promote COVID-19 Testing · NA · completed
- NCT04179149 — Enriched Environments in Endometriosis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06883058 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ponce Medical School Foundation, Inc.
- Last refreshed: 19 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06883058.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing